CRO Intel
Dashboard
Companies
Opportunity Signals
Clinical Trials
Hiring Intelligence
Funding
Publications
FDA
Settings
Company Intelligence
Discover companies with clinical, regulatory and hiring signals
Sync Companies
All States
California
Texas
Massachusetts
All Types
Biotech
Pharma
CRO
Total Companies
6,643
Company
Clinical Trials
FDA Signals
Hiring
Opportunity
Confidence
Last Seen
Guangzhou Renuma Medical Systems
—
—
—
60
40%
7/20/2026
View Intelligence
Guangzhou Ruianbo Pharmaceutical Technology
—
—
—
60
36%
7/17/2026
View Intelligence
Guangzhou Sinogen Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Guangzhou Tata Biotechnology
—
—
—
60
42%
7/20/2026
View Intelligence
Guangzhou Virotech Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Guangzhou Xin-chuangyi Biopharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Guangzhou Yapeng Refinement Chemical
—
—
—
60
39%
7/20/2026
View Intelligence
Guangzhou Yilong Cosmetics
—
—
—
60
40%
7/20/2026
View Intelligence
Guangzhou Yipinhong Pharmaceutical Coltd
—
—
—
60
36%
7/17/2026
View Intelligence
Guard Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Guardian Drug
—
—
—
60
42%
7/20/2026
View Intelligence
Guerlain
—
—
—
60
42%
7/20/2026
View Intelligence
Guided Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Guidon Pharmaceutics
—
—
—
60
36%
7/17/2026
View Intelligence
Guizhou Bailing Group Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Guizhou Tongjitang Pharmaceutical Coltd
—
—
—
60
36%
7/17/2026
View Intelligence
Guizhou Yi Bai Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Guna spa
—
—
—
60
42%
7/20/2026
View Intelligence
Gunkang Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Guoxin Pharmaceutical Technology (beijing)
—
—
—
60
36%
7/17/2026
View Intelligence
Gut-brain-axis Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Gv20 Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Gvk Biosciences
—
—
—
60
36%
7/17/2026
View Intelligence
Gw Pharmaceuticals
—
—
—
60
36%
7/17/2026
View Intelligence
Gx Pharma Technology (beijing)
—
—
—
60
36%
7/17/2026
View Intelligence
Gyala Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
Gylden Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Gyroscope Therapeutics
—
—
—
60
36%
7/17/2026
View Intelligence
H E BUTT GROCERY
—
—
—
60
40%
7/20/2026
View Intelligence
H2 Nutrition
—
—
—
60
40%
7/20/2026
View Intelligence
H2-Pharma
—
—
—
60
42%
7/20/2026
View Intelligence
HART Health
—
—
—
60
42%
7/20/2026
View Intelligence
HARTMAN BROTHERS
—
—
—
60
39%
7/20/2026
View Intelligence
HAWAII REPACK
—
—
—
60
41%
7/20/2026
View Intelligence
HCBIOPHARM
—
—
—
60
42%
7/20/2026
View Intelligence
HEB
—
—
—
60
42%
7/20/2026
View Intelligence
HF Acquisition DBA HealthFirst
—
—
—
60
42%
7/20/2026
View Intelligence
HHH Pharmaceuticals
—
—
—
60
40%
7/20/2026
View Intelligence
HISTORICAL REMEDIES LLP
—
—
—
60
42%
7/20/2026
View Intelligence
HONESTLY
—
—
—
60
40%
7/20/2026
View Intelligence
HP Halden Pharma AS
—
—
—
60
40%
7/20/2026
View Intelligence
HRR Enterprises
—
—
—
60
40%
7/20/2026
View Intelligence
HUNTERS BEACH LIFE
—
—
—
60
40%
7/20/2026
View Intelligence
Hac Pharma
—
—
—
60
36%
7/17/2026
View Intelligence
Haffkine Bio-pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Hahnemann Laboratories
—
—
—
60
42%
7/20/2026
View Intelligence
Haihe Biopharma
—
—
—
60
36%
7/17/2026
View Intelligence
Hain Celestial Group
—
—
—
60
40%
7/20/2026
View Intelligence
Hainan General Sanyang Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Hainan Linheng Pharmaceutical
—
—
—
60
36%
7/17/2026
View Intelligence
Showing
2551
-
2600
of
6,643
companies
Previous
50
51
52
53
54
Next